Michael L. Peterson, Director at TRXADE GROUP, INC. (MEDS), sold 1,800 shares at $5.26 ($9K) on 2020-12-14, disclosed to the SEC on 2020-12-15.
Scheduled sale ($9k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PED | SELL | 2018-06-29 | $352K | — | Filing → |
| PED | SELL | 2017-12-29 | $8K | — | Filing → |
| PED | SELL | 2017-10-11 | $585 | — | Filing → |